Clopidogrel Completed Phase 3 Trials for Renal Insufficiency,Chronic / Coronary Artery Disease / Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02294643Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
NCT00823212The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
NCT01510327PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
NCT01500434The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)
NCT01543932High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients
NCT02070159Prasugrel With Lower Dose - Loading Dose
NCT00822666Clopidogrel and Response Variability Investigation Study 2
NCT00693069Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function
NCT01032668The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance
NCT01813435GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
NCT01304472Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment